Skip to content

The Relationship between the dose of Epoetin Beta Pegol for treatment of renal anemia and renal prognosis in CKD Patients

The Relationship between the dose of Epoetin Beta Pegol for treatment of renal anemia and renal prognosis in CKD Patients - The Relationship between the dose of Epoetin Beta Pegol and renal prognosis in CKD Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000011237
Enrollment
50
Registered
2013-07-20
Start date
2013-07-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal anemia in CKD patients not on hemodialysis

Interventions

None listed

Sponsors

Toda Central General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)CKD patients not on dialysis with the hemoglobin level less than 11g/dL (2)Patients with no prior treatment with ESA agents

Exclusion criteria

Exclusion criteria: (1) Anemia for other reasons than the renal anemia: 1) Iron deficiency (Serum ferritin <100 ng/mL and transferrin saturation <20%) 2) Vitamin B12 deficiency 3) Folic acid deficiency 4) Apparent hemorrhagic lesion 5) hematologic disease (e.g. leukemia, malignant lymphoma, myelodysplastic syndrome, aplastic anemia) 6) Disease associated with chronic inflammation (e.g. rheumatoid arthritis, inflammatory bowel disease) 7) Under myelosuppressive therapy (immunosuppressive therapy, chemotherapy or radiotherapy) (2) Under treatment for malignansy and severe infection (3) Post renal transplant patient (4) Hypersensitivity to epoetin beta pegol (5) Pregnancy or lactating (6) eGFR <6.0 mL/min/1.73 m2

Design outcomes

Primary

MeasureTime frame
Renal prognosis 1) time to doubling of serum creatinine level 2) time to entry in a hemodialysis 3) time to decreace in eGFR to less than 6.0 mL/min/1.73 m2

Countries

Japan

Contacts

Public ContactJUN Jun

Toda Central General Hospital Department of Nephrology

pikkun46@umin.or.jp048-442-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026